Pyrantelum Owix oral suspension 0.25 g/ 5 ml 15 ml

Pyrantelum Owix oral suspension 0.25 g/ 5 ml 15 ml

100% secure payments
zł25.99
Tax included

Description

Pyrantelum Owix oral suspension 0.25 g/ 5ml 15 ml

Description
Composition and form: 5 ml of oral suspension contains 250 mg of pyrantel (Pyrantelum) in the form of pyrantel embonate (721 mg). Excipients with known effect: sorbitol 70% (E 420), sodium benzoate (E 211), glycerol, ethanol (from flavor), propylene glycol (from flavor), geraniol (from flavor), benzyl alcohol (from flavor). Each ml of suspension contains: 519.05 mg of sorbitol (E 420); 3 mg sodium benzoate (E 211); 60.7 mg glycerol; 0.9 mg ethanol; 0.04 mg propylene glycol; 0.081 micrograms of geraniol and 0.04 micrograms of benzyl alcohol.


Indications: Enterobius vermicularis in children from 2 years of age and adults.
Storage and use
How to use: Use as directed by your doctor
Detailed instructions for use can be found in the leaflet included in the package.

Storage: Store at ambient temperature
Composition
Pyrantel
Manufacturer
Zakłady Farmaceutyczne Polpharma S.A.
Manufacturer address
Zakłady Farmaceutyczne Polpharma S.A.,
street Pelplińska 19,
83-200 Starogard Gdański,
EN
Security Warning
Use with caution in children under 2 years of age. In this age group, Pyrantelum Owix should only be used under medical supervision. In patients with hepatic impairment, caution should be exercised and blood AST levels should be monitored. It may be necessary to reduce the dose. Caution should be exercised when using the medicinal product in malnourished or anemic patients. Sorbitol 70% (E 420).The medicinal product contains 519.05 mg sorbitol in each ml of suspension (corresponding to 10,381 mg sorbitol in each 20 ml of suspension). Patients with hereditary problems of fructose intolerance must not take this medicinal product. Sorbitol may cause digestive discomfort and may have a mild laxative effect. The additive effects of concomitantly administered products containing fructose (or sorbitol) and food containing fructose (or sorbitol) should be taken into account. Sorbitol contained in the medicinal product may affect the bioavailability of other medicinal products administered simultaneously orally. Sodium benzoate (E 211). This medicinal product contains 3 mg sodium benzoate in each ml of suspension (corresponding to 60 mg sodium benzoate in each 20 ml of suspension). Sodium. This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially 'sodium-free'. Ethanol. The medicinal product contains 0.9 mg of alcohol (ethanol) in each ml of suspension. The amount of alcohol in 1 ml of this medicinal product is equivalent to less than 1 ml of beer or 1 ml of wine. The small amount of alcohol in this medicinal product will not cause any noticeable effects. Benzyl alcohol. This medicinal product contains 0.04 micrograms of benzyl alcohol in each ml of suspension (corresponding to 0.81 micrograms of benzyl alcohol in each 20 ml of suspension). Benzyl alcohol may cause allergic reactions.

Product Details

Polpharma
9 Items

Specific References

EAN13
5909990276417

Reviews

No customer reviews for the moment.